Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
4 min read
Pharmaceutical Insights: Miglustat's R&D Progress and its Mechanism of Action on Drug Target
28 September 2023
This article summarized the latest R&D progress of Miglustat, the Mechanism of Action for Miglustat, and the drug target R&D trends for Miglustat.
Latest Hotspot
3 min read
Hepagene Therapeutics Confirms FDA Approval of Experimental New Drug Application (IND) for HPG7233 THR Beta Stimulant
28 September 2023
Hepagene Therapeutics revealed that its IND application forHPG7233 has been approved by the FDA in the United States.
Drug Insights
4 min read
Exploring Methylergonovine Maleate's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
28 September 2023
This article summarized the latest R&D progress of Methylergonovine Maleate, the Mechanism of Action for Methylergonovine Maleate, and the drug target R&D trends for Methylergonovine
Advanced Tech.
7 min read
The Application of CAR-T in Multiple Myeloma
28 September 2023
Currently, CAR-T therapy has promising potential in the field of multiple myeloma treatment.
Drug Insights
4 min read
Decoding Methoxsalen: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
27 September 2023
This article summarized the latest R&D progress of Methoxsalen, the Mechanism of Action for Methoxsalen, and the drug target R&D trends for Methoxsalen.
Latest Hotspot
2 min read
Sapience Therapeutics announces ST101 clinical results at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
27 September 2023
Sapience Therapeutics publicizes the demonstration of ST101 Clinical findings at the International Conference on Molecular Targets and Cancer Therapeutics held by AACR-NCI-EORTC in 2023.
Drug Insights
4 min read
Deep Scientific Insights on Margetuximab's R&D Progress, Mechanism of Action, and Drug Target
27 September 2023
This article summarized the latest R&D progress of Margetuximab, the Mechanism of Action for Margetuximab, and the drug target R&D trends for Margetuximab.
Valuable Targets
5 min read
Analysis on the Clinical Research Progress of CYP2C9 Inhibitors
27 September 2023
CYP2C9 is a member of the Cytochrome P450 superfamily of enzymes that primarily metabolize drugs in the human body.
Drug Insights
4 min read
An In-depth Analysis of Labetalol Hydrochloride's R&D Progress and Mechanism of Action on Drug Target
27 September 2023
This article summarized the latest R&D progress of Labetalol Hydrochloride, the Mechanism of Action for Labetalol Hydrochloride, and the drug target R&D trends for Labetalol Hydrochloride.
Latest Hotspot
3 min read
SpyBiotech reports submission of Clinical Trial Application to MHRA for SPYVLP01
27 September 2023
SpyBiotech has declared that they've submitted a clinical trial request to the U.K. MHRA for SPYVLP01 assessment.
Drug Insights
4 min read
Temsirolimus: Detailed Review of its Transformative R&D Success, Mechanism of Action, and Drug Target
27 September 2023
This article summarized the latest R&D progress of Temsirolimus, the Mechanism of Action for Temsirolimus, and the drug target R&D trends for Temsirolimus.
Bio Sequence
3 min read
CAR-T Core Functional Component Sequence Retrieval Strategy
27 September 2023
Chimeric antigen receptor (CAR) T cell therapy, in which a patient’s own T lymphocytes are engineered to recognize and kill cancer cells, has achieved remarkable success in some hematological malignancies in preclinical and clinical trials.